IDH Inhibitors and MDS

preview_player
Показать описание
Considerations for treating patients with myelodysplastic syndromes and acute myeloid leukemia with an IDH inhibitor.

  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
IDH Inhibitors and 0:04:06

IDH Inhibitors and MDS

IDH inhibitors for 0:01:32

IDH inhibitors for AML and MDS

The impact of 0:01:14

The impact of IDH mutations in MDS & evaluating the role of IDH inhibitors

The prognostic impact 0:02:53

The prognostic impact of IDH mutations and the role of IDH inhibitors in MDS

Trends in AML 0:02:09

Trends in AML and MDS at ASH 2021

IDH Inhibitors for 0:02:05

IDH Inhibitors for Cholangiocarcinoma

IDH Inhibitors for 0:08:50

IDH Inhibitors for AML

How Do IDH 0:00:39

How Do IDH Inhibitors Work?

IDH inhibitors 0:01:59

IDH inhibitors

From MDS to 0:34:15

From MDS to AML: What Every Patient Needs to Know 11/28/17

AML Treatment Challenges 0:18:29

AML Treatment Challenges Who, When, and How

Differences and similarities 0:01:09

Differences and similarities between MDS and AML & how this can inform treatment decisions

Phase II trial 0:02:01

Phase II trial of enasidenib in IDH2-mutant MDS

Differentiation Syndrome and 0:09:08

Differentiation Syndrome and IDH Inhibitors in AML

The impact of 0:02:08

The impact of IDH mutations on the outcomes of patients with AML & inhibitors under investigatio...

IDH1/2 Inhibitors in 0:06:35

IDH1/2 Inhibitors in AML

Are IDH1/IHD2 mutations 0:02:10

Are IDH1/IHD2 mutations more or less common in MDS than in AML?

When is Treatment 0:25:30

When is Treatment Needed for Myelodysplastic Syndrome (MDS)?

Venetoclax-IDH inhibitor combination 0:03:08

Venetoclax-IDH inhibitor combination therapy for AML

Options for Treatment 0:26:05

Options for Treatment of MDS

What is the 0:02:20

What is the role of IDH1 and IDH2 inhibitors in the treatment of MDS?

Dr. McCloskey Discusses 0:02:15

Dr. McCloskey Discusses IDH Inhibitors in AML

IDH1/2 inhibitors for 0:01:51

IDH1/2 inhibitors for upfront AML therapy and transfusion independence

Community Perspectives on 1:32:49

Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome